Hims & Hers Health, Inc. · NYSE:HIMS
Hims & Hers Health — Q2 2026 Earnings Presentation
39 slides from Hims & Hers Health's earnings presentation, Aug 10, 2026
Slide 1: Investor Presentation August 2026
hims x hers SUPPLEMENTAL PRESENTATION Investor Presentation August 2026
Slide 2: Safe Harbor Statement
INTRODUCTION Safe Harbor Statement This presentation has been prepared by Hims & Hers Health, Inc. (“we,” “us,” “our,” “Hims & Hers,” or the “Company”. This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of
Slide 3: Feeling good in your body & mind transforms how you show up in life
INTRODUCTION Feeling good in your body & mind transforms how you show up in life himsshers
Slide 4: Our platform democratizes access to high-quality personalized care
INTRODUCTION Our platform democratizes access to high-quality personalized care, by leveraging technology to deliver a frictionless customer experience himsshers
Slide 5: Our team is led by a visionary founder
INTRODUCTION Our team is led by a visionary founder, with support from a leadership team that has scaled transformative organizations 2 2@ 2 2 @ Mike Chi Chief Operating Officer ZOLA Andrew Dudum Chief Executive Officer & Co-Founder ATOMIC 2 Dr. Pat Carroll Global Chief Medical Officer Ww Yemi Okupe
Slide 6: We believe we have the ability to help over 100 million consumers
INTRODUCTION We believe we have the ability to help (50% over 100 million consumers across 90% Through normalizing and innovating, our platform can the specialties and regions we serve unlock solutions for millions of potential customers . Te Yi @ Active ¢ q i Weight Loss, Sexual Health Dermatology
Slide 7: Our platform has evolved from convenient, transparent access to care
INTRODUCTION Our platform has evolved from convenient, transparent access to care to data-driven personalization, now delivered through an Al-powered customer experience Bounecodmeudrenasdedusedadeesonecanenanseccg RCLENIGREUMTEEN coccccaccsccconcaaceqasnacancanccessan|cd™ Convenient, Transparent, D
Slide 8: Our platform uses AI to integrate deep insights
INTRODUCTION Our platform uses Al to integrate deep insights, high-touch acccess to care, and best-in-class solutions into one personalized experience = Cori! himsshers
Slide 9: Our Strategy
Our Strategy —
Slide 10: Our value proposition strengthens with each new subscriber
STRATEGY 10 Our value proposition More subscribers —— Asstiaarers strengthens with each — ., bystructured data new subscriber, . oii getting smarter with * @ @ every interaction / 7 — a © checkrecords ' ’ Data-driven High quality — personalized solutions outcomes and services = oS Clinical Excellenc
Slide 11: Brand investment positions Hims & Hers to become synonymous with access to high-quality care
STRATEGY Brand investment positions Hims & Hers to become synonymous with access to high-quality care Presence in Most Thought Leaders Distinct Brands Culturally Relevant Across Our with Distinct Global Moments Specialties Approaches TheShape el BS of America é = Fe] es himsshers
Slide 12: Our AI-native technology platform provides consumers with convenient and rapid access
STRATEGY Our Al-native technology platform provides consumers with convenient and rapid access to personalized care ~~ Your Action Planis ready lh What can Ido to get better results? Helping people better Access to proactive, Democratizing Reducing the cost understand their overall always-on care th
Slide 13: Growth is re-accelerating across our U.S. business
STRATEGY Growth is re-accelerating across our U.S. business, driven by our expanding ability to do more for customers hims Launching more offerings at a faster rate Hims year-over-year revenue growth began to mS ) Testosterone re-accelerate in the second quarter Launched Sep 2025 Hims subscribers ad
Slide 14: A consistent focus on curating innovative solutions and services
STRATEGY 4 A consistent focus on curating innovative solutions and services is leading to deeper customer — relationships and a more diverse customer base More Structured Subscribers Data Richard Damian Anna LATE 30s Y MID-40s EARLY 50s Concerns eericenre Concerns Wants to lose weight sustainably Cu
Slide 15: An ecosystem that provides subscribers value beyond medication
STRATEGY An ecosystem that provides subscribers value Subscribers Personalized beyond medication is proving to be vital in building — long-term customer relationships Insights Progress Support § g § Richard LATE 30s Weight Loss Habits | 2DaySteak ~ = -@@5 24/7 Messaging Damian = A0- ij, ‘ MID-40s er
Slide 16: Our multi-year investments in our domestic facilities
STRATEGY More Structured Subscribers Data Our multi-year investments in our domestic facilities drive our ability to provide efficient and affordable — access to this personalized experience CA OH y’ NJ AZ Lab testing increases visibility Our facility footprintin the US now exceeds 1 million square
Slide 17: Clinical excellence drives high quality outcomes
STRATEGY w Clinical excellence drives high quality outcomes & More Structured Subscribers Data Our Medical Executives help form the Manufacturing and supply chain foundation of our clinical excellence FDA and state regulated facilities and third-party testing of combined experience Clinical excellen
Slide 18: High-quality service levels and a personalized experience
STRATEGY B High-quality service levels and a personalized experience across a range of specialties are driving a leadership position Share of Observed Total Sales Share of Observed Total Customers ae 9.0% 11.9% 12.7% 11.6% 11.1% a 23.7% 6.3% 7 ee —— eS 25.5% 20.3% 6% uaa 6.7% 6.2% 11.0% 14.7% 9.5% =
Slide 19: Long-Term Vision
Slide 20: Execution and foundational capabilities that are positioned to scale
VISION Execution and foundational capabilities that are positioned to scale give us confidence in achieving our 2030 financial targets 2030 Revenue 2030 Adjusted EBITDA’ of atleast of atleast $1.3B+
Slide 21: Our long-term roadmap will be driven by five key growth levers
VISION Our long-term roadmap will be driven by an ongoing focus across five key growth levers Deeper Expansion into Elevate the Strategic Global expansion personalized new emotionally precision of care partnerships of our platform experiences resonant from beginning and investments specialties toend
Slide 22: Recent acquisitions strengthen our value proposition in the near term
VISION Recent acquisitions strengthen our value proposition in the near term, and provide a foundation for our long-term vision eee cece eeeeeeees CAPABILITIES seeeeccccccsceces se eeeeeeeeeee INTERNATIONALEXPANSION eeeeeeeeeees Outsourcing Facility Acquired sep. 2024 ZAVA Acquired Jul.2025 Leading
Slide 23: Building a global, customer-first healthcare platform through strategic M&A
VISION Building a global, customer-first healthcare platform through strategic M&A and targeted investments North America 280M+ Est. population nua a 4 2% Launched H&H Canada in November 2025 through Canadian acquisition Australia 20M+ Est. population Entered Australia through the Eucalyptus acquisi
Slide 24: AI-supported care across the entire health journey
VISION Al-supported care across the entire health journey, powered by the world’s leading end-to-end, global consumer health platform Smarter intake Chatbot powered dynamic intake seamlessly identifies customer's symptoms, goals, and history Labs, biomarkers, and customer-reported data create a rich
Slide 25: Financials
mlatclarerelis
Slide 26: Our subscriber count and customer engagement drive revenue growth
FINANCIALS 26 Our subscriber count and customer engagement drive revenue growth ts NUMBER OF SUBSCRIBERS! + sees ee eeeeeceseeeceeee ee eee REVENUE PER SUBSCRIBER! +2000 Acquisition Retention Engagement on Multi-condition care > Proactive care companions brand development New specialties + solutions
Slide 27: Revenue growth driven by expanding subscribers, entry into new geographies
FINANCIALS ar Revenue growth driven by expanding subscribers, entry into new geographies, and increasing revenue per average subscriber Subscribers' Total Subscribers (millions) +19% Q2 ‘26 YoY a Q3'24 Q4'24 Qi'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Revenue fo) Monthly rev. /2 per avg. subscriber | Total
Slide 28: Strong and consistent unit economics have provided a foundation to scale
FINANCIALS 28 Strong and consistent unit economics have provided a foundation to scale with confidence Proven ability to consistently drive <1 yr <lyr Q1‘25 Cohort payback period! over the last 5 years less than one year payback period’ (in-line with our capital allocation framework) @ > Payback per
Slide 29: The scalability of our model enables consistent Adjusted EBITDA profitability
FINANCIALS The scalability of our model enables consistent Adjusted EBITDA profitability as we invest behind long-term opportunities @ Adjusted EBITDA’ ($ millions) @ Adjusted EBITDA margin’ (percentage) 16% 15% 13% Roughly 500 basis points of market leverage YoY investment across engineering, Growi
Slide 30: New specialties and a more comprehensive personalized experience position us to scale
FINANCIALS 30 New specialties and a more comprehensive personalized experience position us to scale and accelerate growth throughout 2026 — $3.10-$3.30 59% | Total revenue ($ billions) 69% | YoY revenue growth 65% 94% $0.87 — 2021 2022 2023 2024 2025 2026' labs labs hormone health hormone health wei
Slide 31: Significant investment and targeted M&A are enabling international markets
FINANCIALS Significant investment and targeted M&A are enabling international markets to quickly become a key growth driver International Revenue §) International revenue ($ millions) Key Milestones Honest Health H&H Canada Acquired Jul. 2021 Launched Nov. 2025 F (+) seteee ° ° ° ° ° e—------ Qi'25
Slide 32: Strong balance sheet is enabling investment across multiple opportunities
FINANCIALS 32 Strong balance sheet is enabling investment across multiple opportunities, reinforcing our long-term trajectory @ Operating Cash Flow ($ millions) Free Cash Flow’ ($ millions) fe) Cash, ST and LT Investments ($ millions) $1,144 $1,068 Over $840M in cash tand ST investments provides fle
Slide 33: 2026 outlook anticipates an accelerating growth profile
FINANCIALS 2026 outlook anticipates an accelerating growth profile and consistent Adjusted EBITDA generation Q3 2026 FY 2026 Revenue $880M-$900M $3.1B-$3.3B YoY growth 47%-50% 32%-41% Adj. EBITDA’ $75M-$95M $275M-$325M Adj. EBITDA margin’ ~10% ~9% 2026 Underlying Themes @) 85%+ long-term retention?
Slide 34: Capital investments in 2026 are focused on unlocking access to higher quality care
FINANCIALS 34 Capital investments in 2026 are focused on unlocking access to higher quality and more personalized care for millions of individuals investments and partnerships Increased breadth of personalization Acceleration of new specialties data intelligence layer International expansion Eucalyp
Slide 35: Appendix
Appendix
Slide 36: Non-GAAP Financial Measures
APPENDIX Non-GAAP Financial Measures In addition to our financial results determined in accordance with US. GAAP, we present Adjusted EBITDA (which is a non-GAAP financial measure), Adjusted EBITDA margin (which is a non-GAAP ratio), and Free Cash Flow (which is a non-GAAP financial measure), each a
Slide 37: Net (Loss) Income to Adjusted EBITDA Reconciliation
APPENDIX Net (Loss) Income to Adjusted EBITDA Reconciliation ($ thousands, unaudited) Q3’24 Revenue $401,556 Net (loss) income $75,588 Legal contingencies - Stock-based compensation $24,899 Depreciation and amortization $4,383 Acquisition and transaction-related costs $858 Restructuring and other re
Slide 38: Net Cash to Free Cash Flow Reconciliation
APPENDIX Net Cash (Used In) Provided By Operating Activities to Free Cash Flow Reconciliation ($ thousands, unaudited) Net cash (used in) provided by operating activities Purchases of property, equipment, and intangible assets in investing activities Investment in website development and internal-us
Slide 39: Sources
APPENDIX Sources In order of appearance: ‘Ogunwole, S., Rabe, M., Roberts, A., & Caplan, Z. (2021, August 12). U.S. Adult Population Grew Faster Than Nation's Total Population From 2010 to 2020. The United States Census Bureau. Estimates of the population for the UK, England and Wales, Scotland and